Filter
472
Text search:
immunity
Featured
Recommendations
48
New Publications
111
Language
Document type
No document type
214
Guidelines
79
Studies & Reports
70
Fact sheets
31
Manuals
29
Strategic & Response Plan
17
Training Material
16
Situation Updates
7
Resource Platforms
4
Videos
3
Infographics
1
Online Courses
1
Countries / Regions
Global
23
India
15
Kenya
12
Nigeria
11
Brazil
11
Africa
10
Latin America and the Carribbean
9
South Africa
8
Sierra Leone
7
Rwanda
7
Venezuela
7
Congo, Democratic Republic of
6
Malawi
6
Bangladesh
5
West and Central Africa
5
South–East Asia Region
5
Western and Central Europe
5
Pakistan
4
Afghanistan
4
Syria
4
Tanzania
4
Myanmar / Burma
4
Middle East and North Africa
4
Russia
4
Liberia
3
Ethiopia
3
Uganda
3
Zimbabwe
3
Philippines
3
Somalia
3
South Sudan
3
Cambodia
3
Mozambique
3
Ukraine
3
East and Southern Africa
3
Nepal
2
Germany
2
Lebanon
2
Zambia
2
Papua New Guinea
2
Argentina
2
Namibia
2
Lesotho
2
Chile
2
Yemen
2
Vietnam
2
Guinea
1
Burkina Faso
1
Guinea-Bissau
1
USA
1
Ghana
1
Haiti
1
Iraq
1
Turkey
1
Indonesia
1
Singapore
1
Central African Republic
1
Peru
1
North Macedonia
1
Colombia
1
Angola
1
Western Pacific Region
1
Other region
1
Asia
1
Eastern Europe
1
Laos
1
Kazakhstan
1
France
1
United Kingdom
1
Portugal
1
Spain
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
139
Clinical Guidelines
62
Key Resources
28
Public Health
25
Women & Child Health
25
Capacity Building
5
Pharmacy & Technologies
5
Toolboxes
COVID-19
104
TB
34
NTDs
29
Polio
20
Rapid Response
19
HIV
19
Ebola & Marburg
12
Mental Health
11
AMR
11
Planetary Health
10
2.0 Rapid Response
9
Zika
8
Caregiver
8
NCDs
8
Conflict
7
Refugee
7
Global Health Education
5
Malaria
5
Specific Hazards
4
Pharmacy
4
Cholera
3
Natural Hazards
3
Health Financing Toolbox
3
Disability
1
Typhoon
1
Mem Inst Oswaldo Cruz , Rio de Janeiro, Vol. 110 (3): 377-386, May 2015
Abstract: Chagas disease is caused by infection with the protozoan Trypanosoma cruzi, and although over 100 years have passed since the discovery of Chagas disease, it still presents an increasing problem for global public health. A plethora of information concerning the chronic phase of human Chaga
...
The report reviews progress with the task of planning and implementing measures necessary to secure a completely polio-free world. It also examines actions aimed at ensuring successful transfer of polio assets, innovations developed and lessons learned to countries’ public health programmes and ot
...
Rabies is fatal, vaccine-preventable disease responsible for an estimated 59,000 human deaths each year. Most cases are transmitted by dogs, and most deaths occur in underserved populations in Africa and Asia. Approximately 40% of deaths occur in children.
The 12th Meeting of the Regional Certification Commission (RCC) for the Polio Endgame in the Region of the Americas was conducted virtually due to the pandemic of COVID-19. The meeting was composed of 5 steps:
Step 1: An introductory meeting between RCC members and Secretariat
Step 2: Assessment
...
A guide for doctors providing health services for children. 2nd edition
This document is intended to serve as a reference for national public health policy-makers. It outlines the scope of potential meningitis surveillance strategies that make it possible to obtain the data required for epidemic detection, monitoring of epidemiological and microbiological trends, evalua
...
The ECDC Communicable Disease Threats Report (CDTR) is a weekly bulletin for epidemiologists and health professionals on active public health threats. This issue covers the period 5-11 November 2017 and includes updates on measles, rubella, chikungunya, West Nile virus, Plague, monkeypox, legionnair
...
Monkeypox is an emerging viral zoonosis with symptoms similar to those observed in smallpox patients, although less severe. Since the global eradication of smallpox in 1980, monkeypox has emerged as the most important orthopoxvirus in humans. The Advisory Committee on Variola Virus Research (ACVVR)
...
An Action Framework and annexe to Immunization Agenda 2030 (Draft version)
27 January 2021
Interim Guidance October 2022. This addendum addresses some of the methodological aspects of VE evaluations that have been learned during the past year, as well as those that have become relevant in the current epidemiological setting of the COVID-19 pandemic. For some of the COVID-19 vaccine method
...
